title: In vitro priming to tumor-associated proteins.
authors.affiliation: University of Washington, Seattle, USA.
authors.forename: S L
authors.initials: SL
authors.lastname: Hand
authors.forename: H
authors.initials: H
authors.lastname: Bernhard
authors.forename: E S
authors.initials: ES
authors.lastname: Huseby
authors.forename: W D
authors.initials: WD
authors.lastname: Rubin
authors.forename: M L
authors.initials: ML
authors.lastname: Disis
authors.forename: M A
authors.initials: MA
authors.lastname: Cheever
mesh_terms: D000818:Animals; D000951:Antigens, Neoplasm / Q000008:administration & dosage*; D003713:Dendritic Cells / Q000276:immunology*; D006801:Humans; D016219:Immunotherapy, Adoptive / Q000379:methods*; D066298:In Vitro Techniques; D008213:Lymphocyte Activation; D009363:Neoplasm Proteins / Q000276:immunology*; D009369:Neoplasms / Q000276:immunology / Q000628:therapy; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology
chemical_list: D000951:Antigens, Neoplasm; D009363:Neoplasm Proteins; D018719:Erb-b2 Receptor Tyrosine Kinases